Sesen Bio, Inc. SESN Stock
Sesen Bio, Inc. Price Chart
Sesen Bio, Inc. SESN Financial and Trading Overview
| Sesen Bio, Inc. stock price | 0.63 USD |
| Previous Close | 0.59 USD |
| Open | 0.57 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1300 |
| Day's Range | 0.57 - 0.63 USD |
| 52 Week Range | 0.37 - 0.97 USD |
| Volume | 1.78M USD |
| Avg. Volume | 1.17M USD |
| Market Cap | 127.96M USD |
| Beta (5Y Monthly) | 0.829533 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 6, 2023 |
| 1y Target Est | 12 USD |
SESN Valuation Measures
| Enterprise Value | 2.39B USD |
| Trailing P/E | N/A |
| Forward P/E | -1.0479999 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.1988943 |
| Price/Book (mrq) | 0.80615383 |
| Enterprise Value/Revenue | 59.805 |
| Enterprise Value/EBITDA | -62.349 |
Trading Information
Sesen Bio, Inc. Stock Price History
| Beta (5Y Monthly) | 0.829533 |
| 52-Week Change | -13.83% |
| S&P500 52-Week Change | 4.67% |
| 52 Week High | 0.97 USD |
| 52 Week Low | 0.37 USD |
| 50-Day Moving Average | 0.6 USD |
| 200-Day Moving Average | 0.62 USD |
SESN Share Statistics
| Avg. Volume (3 month) | 1.17M USD |
| Avg. Daily Volume (10-Days) | 1.74M USD |
| Shares Outstanding | 203.49M |
| Float | 187.28M |
| Short Ratio | 2.34 |
| % Held by Insiders | 8.98% |
| % Held by Institutions | 16.00% |
| Shares Short | 2.12M |
| Short % of Float | 1.05% |
| Short % of Shares Outstanding | 1.05% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -49.71% |
| Operating Margin (ttm) | -95.95% |
| Gross Margin | 95.03% |
| EBITDA Margin | -95.91% |
Management Effectiveness
| Return on Assets (ttm) | -11.15% |
| Return on Equity (ttm) | -12.055% |
Income Statement
| Revenue (ttm) | 40M USD |
| Revenue Per Share (ttm) | 0.2 USD |
| Quarterly Revenue Growth (yoy) | -100.00000000000000000000000000000000% |
| Gross Profit (ttm) | 38.02M USD |
| EBITDA | -38368000 USD |
| Net Income Avi to Common (ttm) | -19884000 USD |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 166.92M USD |
| Total Cash Per Share (mrq) | 0.82 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.105 |
| Book Value Per Share (mrq) | 0.78 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 24.9M USD |
| Levered Free Cash Flow (ttm) | 23.46M USD |
Profile of Sesen Bio, Inc.
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 245 First Street |
| ZIP | 02142 |
| Phone | 617 444 8550 |
| Website | https://sesenbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Q&A For Sesen Bio, Inc. Stock
What is a current SESN stock price?
Sesen Bio, Inc. SESN stock price today per share is 0.63 USD.
How to purchase Sesen Bio, Inc. stock?
You can buy SESN shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sesen Bio, Inc.?
The stock symbol or ticker of Sesen Bio, Inc. is SESN.
Which industry does the Sesen Bio, Inc. company belong to?
The Sesen Bio, Inc. industry is Biotechnology.
How many shares does Sesen Bio, Inc. have in circulation?
The max supply of Sesen Bio, Inc. shares is 202.76M.
What is Sesen Bio, Inc. Price to Earnings Ratio (PE Ratio)?
Sesen Bio, Inc. PE Ratio is 0.00000000 now.
What was Sesen Bio, Inc. earnings per share over the trailing 12 months (TTM)?
Sesen Bio, Inc. EPS is 0 USD over the trailing 12 months.
Which sector does the Sesen Bio, Inc. company belong to?
The Sesen Bio, Inc. sector is Healthcare.
Sesen Bio, Inc. SESN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}